Hematogenomics
1 – 10 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inflammatory bowel disease–induced inflammation augments clonal hematopoiesis of indeterminate potential through Ref-1
- Contribution to journal › Article
-
Mark
Genome-wide association study in 21,271 individuals identifies 9 novel loci associated with circulating CD34
+ hematopoietic stem and progenitor cell levels.
- Contribution to journal › Article
- 2025
-
Mark
Exploring Synergies of Microbial Metabolomics with Other Omics Techniques : Enhancing Drug Discovery and Pharmaceutical Production
(2025) p.203-233
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Functional dissection of the gene regulatory mechanism underlying variation in blood CD34+ cell levels at 1p36.23/ENO1
- Contribution to journal › Article
-
Mark
Genetic variation at PPM1H predicts mobilization efficiency in stem cell donors
- Contribution to journal › Letter
- 2024
-
Mark
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
- Contribution to journal › Article
-
Mark
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1
- Contribution to journal › Article
-
Mark
Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
- Contribution to journal › Article
-
Mark
Association of Somatic TET2 Mutations With Giant Cell Arteritis
- Contribution to journal › Article
